Introduction
The c-myb gene is the cellular progenitor of the retroviral oncogene v-myb of the chicken retroviruses avian myeloblastosis virus (AMV) and avian leukemia virus E26. c-myb encodes a transcription factor (cMyb) and is highly expressed in a wide variety of immature hematopoietic cells. There is a large body of evidence showing that c-myb plays a key role in the development of the hematopoietic system and implicating c-myb in the control proliferation, dierentiation and apoptosis of hematopoietic progenitor cells (for review see : Weston, 1998; Lipsick and Wang, 1999; Oh and Reddy, 1999) . Gene targeting studies in mouse embryonic stem cells have shown that c-myb is an essential gene whose inactivation results in embryonic lethality due to a dramatic decrease in the numbers of erythroid and several other myeloid cell types (Mucenski et al., 1991) . Due to the early embryonic lethality of the c-myb knock-out mice potential eects of c-myb disruption on B-or T-cell development could not be studied in this system. While most of the earlier studies on c-myb have focused on myeloid cells, several recent studies have speci®cally addressed the role of cmyb in the T-lymphoid lineage. Transgenic mice overexpressing a dominant-interfering form of Myb in their T-cells show severe defects of T-cell development partly because thymocytes are undergoing apoptosis (Badiani et al., 1994; Taylor et al., 1996) . The essential role of c-myb in the T-lymphoid lineage was recently con®rmed by using homozygous null c-myb ES-cells and injecting them into RAG1-de®cient mouse embryos to generate chimaeric mice (Allen et al., 1999) . These studies demonstrated that ES-cells lacking a functional c-myb gene cannot develop into mature Tcells. Taken together these data clearly indicate that cmyb is essential for proper T-cell development. In contrast to T-cells, the role of c-myb in B-lymphoid cells is less clear. Proviral insertions into the c-myb gene have been observed in B-cell tumors induced by certain avian retroviruses (Press et al., 1995; Jiang et al., 1997; Smith et al., 1997) . These insertions cause relatively minor truncations of the aminoterminus of cMyb, suggesting that such altered forms of the protein can aect B-cell proliferation and/or dierentiation. During B-lymphocyte dierentiation c-myb is highly expressed up to the pre B-cell stage but not during later stages of dierentiation. Whether c-myb plays a similar role in B-lymphocytes as it does in T-lymphocytes is not yet known. c-myb is also expressed in certain nonhematopoietic cells and tissues. (Desbiens et al., 1991; QueÂ va et al., 1992; Sitzmann et al., 1995; Rosenthal et al., 1996; Ess et al., 1999) . However, in contrast to the hematopoietic system the role of c-myb in nonhematopoietic cells is not well understood at present.
The proteins encoded by c-myb and its oncogenic derivative v-myb (c-Myb and v-Myb) bind to the sequence motif PyAAC G / T G (Biedenkapp et al., 1988) and activate promoters containing such binding sites (Klempnauer et al., 1989; Ness et al., 1989; Weston and Bishop, 1989; Ibanez and Lipsick, 1990) . Several genes have been identi®ed as targets for myb proteins in myeloid cells, such as mim-1 (Ness et al., 1989) , tom-1 , bcl-2 (Frampton et al., 1996; Taylor et al., 1996) , GBX2 (Kowenz-Leutz et al., 1997) c-myc (Evans et al., 1990; Nakagoshi et al., 1992; Zobel et al., 1992; Schmidt et al., 2000) , c-kit (Hogg et al., 1997) , Pdcd4 (Schlichter et al., 2001a) and the genes encoding lysozyme (Introna et al., 1990) , the adenosine receptor 2B (Worpenberg et al., 1997), C/EBPb (Mink et al., 1999) and neutrophil elastase (OelgeschlaÈ ger et al., 1996) . Besides myeloid cells, T-cells have been used to identify the genes regulated by myb proteins (Siu et al., 1992; Hernandez-Munain and Krangel, 1995; Wang et al., 2000; Reizis and Leder, 2001) . The promoters of some of the myb target genes have been analysed in detail and have proven to be useful tools to address the mechanisms by which myb proteins regulate the expression of other genes. For example, in myelomonocytic cells myb proteins activate several of their target genes by cooperating with members of the C/EBP transcription factor family (Burk et al., 1993 Ness et al., 1993) , which themselves are highly expressed in the myelomonocytic lineage. Cooperation of Myb and C/EBP involves interactions of both factors with the coactivator p300/CBP as well as direct contacts between Myb and C/EBP (Mink et al., 1996a (Mink et al., , 1997 .
Homologous recombination occurs at exceptionally high frequencies in the chicken pre-B cell line DT40, making these cells an extremely useful genetic system for targeted gene disruption and for studying gene functions (Buerstedde and Takeda, 1991) . To gain insight into the role of c-myb in B-lymphoid cells we generated a DT40 cell line in which both copies of endogenous c-myb are disrupted. We ®nd that c-myb is not essential for viability of DT40 cells. The c-myb knock-out cells described here should provide a useful model system for the identi®cation and characterization of c-myb target genes in B-lymphoid cells.
Results and discussion

Targeted disruption of c-myb
Genomic clones of the chicken c-myb gene have been described before (Klempnauer et al., 1982) . As illustrated in Figure 1a , we generated the targeting constructs pCMKO-his and pCMKO-puro, in which exons 2 to 9 were replaced with a histidinol or puromycin resistance cassette. Exons 2 to 9 of c-myb account for more than half of the coding region of the gene and include the sequences coding for the c-Myb DNA-binding and transactivation domains. DT40 cells were ®rst transfected with pCMKO-his followed by selection for resistance against 0.5 mg/ml L-histidinol. The resulting clones were then analysed by Southern blotting for disruption of one copy of c-myb. A positive clone was subsequently transfected with pCMKO-puro followed by selection for resistance against 0.5 mg/ml L-histidinol and 1 mg/ml puromycin. Doubly resistant clones were again analysed by Southern blotting to ®nally identify clones in which both copies of c-myb had been disrupted. The genomic Southern blot shown in Figure 1b illustrates the successful targeting of both copies of the c-myb.
To con®rm the disruption of c-myb and to demonstrate the absence of c-myb mRNA and protein in the knock-out cells we analysed wt (+/+), single (+/7) and double (7/7) knock-out cells by Northern and Western blotting. As shown in Figure 2a , c-myb mRNA was expressed at slightly reduced levels in (+/ 7) cells but was no longer detectable in the (7/7) cells. On the protein level, (+/7) cells contained slightly reduced amounts of the 75 000-Mr c-myb Figure 1 Generation of DT40 c-myb (7/7) cells. (a) Schematic representation of the c-myb locus (top), the two targeting constructs (pCMKO-hisD and pCMKO-puro) and the structure of the targeted loci (bottom). Exons of c-myb are indicated by black boxes. The actin promoter (act) and the histidinol (hisD) and puromycin (puro) resistance genes are marked by white arrows and boxes. Relevant HindIII (H), EcoRI (E) BamHI (B) and SacI (S) restriction sites are shown. The probe fragment is indicated by a black bar at the top and the sizes of the HindIII fragments hybridizing with this probe are shown. (b) Southern blot hybridization of wild-type (+/+), heterozygous mutant (+/7) and homozygous mutant (7/7) clones. HindIII-digested genomic DNA (10 mg per lane) was hybridized with the probe shown at the top of a. The dierent intensities of the two bands visible in the third lane are presumably due to less ecient blotting of the larger fragment compared to the smaller one protein. By contrast, the protein was no longer detectable in the (7/7) cells (Figure 2b ). Taken together these data con®rm that we have successfully disrupted both copies of c-myb by homologous recombination.
The ®nding that cells which have lost both copies of c-myb are viable indicated that the c-myb gene is not essential in DT40 cells. To determine if there was any eect on the growth rate due to the absence of c-myb we followed the growth of DT40 (+/+), (+/7) and (7/7) cells (Figure 3a) . The (+/+) and (+/7) cells grew with indistinguishable doubling times while the (7/7) cells grew slightly slower, indicating that the loss of c-myb had only a minor eect on the overall proliferation rate of the cells. We also determined the cell cycle distribution of the (+/+), (+/7) and (7/ 7) cell populations by¯ow cytometry. The resulting patterns (Figure 3b ) displayed distinct peaks of G1-and G2-phase cells, as expected, and looked very similar except that the peak corresponding to G1-phase cells was slightly increased relative to the peak of G2-phase cells in the c-myb knock-out cells. Taken together, these data suggest that the absence of c-myb leads only to a slight distortion of the cell cycle.
Apoptosis is not increased in DT40 cells lacking c-myb
Several studies have implicated c-myb in the control of apoptosis and the regulation of bcl-2 expression. Mouse T-cells expressing a dominant-interfering variant of c-Myb downregulate the expression of the antiapoptotic bcl-2 gene and undergo increased apoptosis (Badiani et al., 1994; Taylor et al., 1996) . Furthermore, v-myb increases the expression of bcl-2 in myeloid cells, thereby preventing apoptosis (Frampton et al., 1996) . We were therefore interested to determine whether the expression of the bcl-2 gene was altered in the DT40 cmyb knock-out cells and whether these cells were more prone to undergo apoptosis than DT40 wt cells. Cultures of DT40 c-myb (+/+) and (7/7) cells contained small numbers of apoptotic cells, however, the percentage of such cells was similar in both cases (data not shown). To study whether c-myb (7/7) cells would respond more eciently to an apoptotic stimulus we compared the kinetics of apoptosis of DT40 (+/+) and (7/7) cells after treatment with cytosine-b-D-arabinofuranoside (Ara-C), which readily triggers apoptosis in DT40 cells. Figure 4 shows that nucleosomal DNA fragments which are indicative of ongoing apoptosis appeared with rather similar kinetics following such treatment. Induction of apoptosis by UV-irradiation also followed a similar time course in DT40 c-myb (+/+) and (7/7) cells (data not shown). To determine possible eects of the disruption of c-myb on bcl-2 expression mRNA from DT40 (+/+), (+/7) and (7/7) cells was analysed by Northern blotting. As illustrated in the top panel of Figure 5 the expression of the bcl-2 gene was not diminished in the absence of c-myb. Thus, we concluded that in DT40 cells bcl-2 expression is not dependent on c-myb. Furthermore, our data provide no evidence for a role of c-myb in the control of apoptosis in these cells.
DT40 c-myb (7/7) show reduced expression of the Pdcd4 gene
Finally, we were interested to determine whether the disruption of c-myb in the DT40 (7/7) cells had any eect on the expression of previously identi®ed myb target genes. Several of these genes, such as mim-1, tom-1, GBX2 and the genes for lysozyme and the A2B adenosine receptor were not expressed in DT40 cells and were excluded from further analysis. Previous studies have shown that c-myc is a myb target gene (Evans et al., 1990; Nakagoshi et al., 1992; Zobel et al., 1992; Schmidt et al., 2000) , however, in contrast to these studies we found that the levels of c-myc mRNA were the same in DT40 (+/+), (+/7) or (7/7) cells ( Figure 5 ). This indicates that c-myb does not contribute signi®cantly to c-myc expression in DT40 cells and raises the possibility that the regulation of cmyc (and possibly bcl-2) by myb may be cell-speci®c. Hogg et al. (1997) have also failed to detect an eect of a c-Myb/estrogen receptor fusion protein on c-myc expression again suggesting that the cellular background plays an important role when assessing the activation of target genes by myb proteins. Pdcd4 is a novel myb target gene which we have identi®ed recently by using a myelomonocytic cell line expressing a conditional version of v-Myb (Schlichter et al., 2001a,b) . As illustrated in Figure 5 Pdcd4 mRNA levels were lower in DT40 (7/7) compared to DT40 (+/+) and (+/7) cells (Figure 5 ), indicating that Pdcd4 expression is regulated by c-myb in DT40 cells. We have recently shown that the promoter of the Pdcd4 gene contains several myb binding sites and is activated by myb proteins in cotransfection experiments (Schlichter et al., 2001b) . Thus, Pdcd4 appears to be a Figure 2 Lack of c-myb mRNA and protein expression in c-myb knock-out cells. (a) Polyadenylated RNA isolated from wild-type (+/+), heterozygous mutant (+/7) and homozygous mutant (7/7) DT40 cells was analysed by Northern blotting using probes speci®c for c-myb (top) and GAPDH (bottom). (b) Whole cell lysates of wild-type (+/+), heterozygous mutant (+/7) and homozygous mutant (7/7) DT40 cells were analysed by SDS ± PAGE and Western blotting using c-Myb speci®c antibodies. Molecular weight markers are indicated on the left. c-Myb is marked by an arrow bona ®de myb target gene in B-lymphoid cells. Clearly, however, the Pdcd4 gene also displays a basal level of myb-independent expression which may account for the observation that the gene is also expressed in nonhematopoietic cells, such as ®broblasts and keratinocytes (Cmarik et al., 1999; Schlichter et al., 2001a) . Although the function of the Pdcd4 gene has not been studied in detail so far, recent work has shown that it can suppress tumor-promoter dependent transformation of keratinocytes (Cmarik et al., 1999) , presumably by regulating signaling events triggered by tumor promoters. By activating Pdcd4 expression myb might therefore indirectly aect such signal transduction pathways in hematopoietic cells.
In conclusion, we have used the chicken pre-B cell line DT40 as a model to address the role of c-myb in Blymphoid cells. Our data show that c-myb, which is highly expressed in DT40 cells is not essential for their viability. In fact, the disruption of c-myb in these cells seems to cause only a minor distortion of the cell cycle. In contrast to studies on murine T-lymphoid cells and chicken myeloid cells the loss of c-myb in DT40 cells also had no obvious eect on the ability of the cells to undergo apoptosis or on the expression of the bcl-2 gene. Together, these ®ndings suggest that the role of Figure 4 Induction of apoptosis in DT40 c-myb (+/+) and (7/ 7) cells. Apoptosis was induced in wild-type or c-myb knock-out DT40 cells by treatment with Ara-C. Cellular DNA was isolated after the indicated time periods and analysed by agarose gel electrophoresis to reveal nucleosomal DNA laddering. Numbers above the lanes refer to hours after addition of Ara-C B A Figure 3 Growth characteristics of DT40 c-myb (+/+), (+/7) and (7/7) cells. (a) Wild-type DT40 c-myb (+/+), (+/7) and (7/7) cells were seeded in growth medium at a concentration of 10 4 cells/ml and their growth was followed over several days. The number of viable cells was determined at the indicated time points. The cumulative cell number was plotted on a logarithmic scale against the time in culture (b). Cell cycle distibution of DT40 c-myb (+/+), (+/7) and (7/7) cells. Cells were stained with propidium iodide and analysed by¯ow cytometry. The horizontal axis indicates the intensity of¯uorescence of a single cell. The vertical axis indicates the cell number. Peaks corresponding to G1-and G2-phase cells are marked c-myb in the B-lymphoid lineage diers signi®cantly from its function in other hematopoietic lineages. Finally, the DT40 c-myb null cells described here provide us with a model system to identify and study myb-regulated genes in the B-lymphoid lineage. As a ®rst step towards this aim we have shown that the Pdcd4 gene, which was originally identi®ed as a v-myb regulated gene in myeloid cells, is a myb target also in B-cells. It will be very interesting to use the DT40 cmyb knock-out cells described here to search for novel target genes of myb in the B-lymphoid lineage.
Materials and methods
Targeting constructs
c-myb targeting vectors were generated by ®rst assembling sequences from chicken c-myb to be used as left and right arms of the targeting constructs in plasmid pBluescript. For this purpose a 6.5 kb HindIII/BamHI fragment from plasmid pCM1 (Klempnauer et al., 1982) and a 1.5 kb BamHI/SacI fragment from plasmid pCM5 (Klempnauer et al., 1982) were cloned into HindIII/SacI digested pBluescript. The BamHI site in each case was derived from the polylinker of the respective plasmid. In the resulting plasmid a unique BamHI site was anked by sequences homologous to the 5' and 3' end of cmyb. The BamHI site was then used to insert a puromycin or histidinol resistance cassette (containing the chicken b-actin promoter and the puromycin or histidinol resistance gene; Bezzubova et al., 1997) . In the resulting targeting vectors, pCMKO-puro and pCMKO-his, the gene conferring resistance to puromycin or histidinol is¯anked by 6.5 and 1.5 kb of sequences homologous to the 5' and 3' end of c-myb.
DNA-transfection and Southern blotting
DT40 cells (Buerstedde and Takeda, 1991) were grown in basal Iscove's medium supplemented with 10% fetal calf serum and 0.001% b-mercaptoethanol. The cells were electroporated by two consecutive electric pulses (1200 V, 25 mF and 160 V, 1500 mF, respectively) with 25 mg of NotIlinearized pCMKO-his followed by selection for resistance against 0.5 mg/ml L-histidinol. Genomic DNA from resistant clones was digested with HindIII and analysed by Southern blotting using a 0.9 kb SacI fragment from plasmid pCM5 as probe. Disruption of one copy of c-myb resulted in the appearance of a novel 6.5 kb HindIII fragment. A heterozygous clone, referred to DT40 c-myb (+/7), was then electroporated with 25 mg of NotI-linearized pCMKO-puro followed by selection in the presence of 1 mg/ml puromycin and 0.5 mg/ml L-histidinol. Genomic DNA from doubly resistant clones was analysed as above. Disruption of the second copy of c-myb was detected by the appearance of a novel 14 kb HindIII fragment. The resulting homozygous cmyb null cells were referred to DT40 c-myb (7/7).
Cell cycle analysis
Cell cycle analysis was performed by washing the cells once in ice-cold PBS, ®xing them with 70% ethanol in PBS for 1 h at 48C and followed by staining with PBS containing 1 mg/ml propidium iodide. FACS analysis was performed using a Becton-Dickinson FACS Calibur. Growth rates were determined by counting the cells in a hemacytometer.
DNA fragmentation analysis
To trigger apoptosis DT40 cells 10 mM cytosine-b-Darabinofuranoside (Ara-C) was added to the growth medium. Cells were cultured further and after dierent time periods samples were lysed in buer containing 10 mM Tris-HCl, pH 7.5; 10 mM EDTA; 150 mM NaCl; 1% (v v 71 ) Triton X-100 and 0.1 mg/ml freshly added Proteinase K, followed by incubation for 20 min at room temperature. Subsequently, 0.1 mg/ml RNase was added and the samples were incubated at 508C for 30 min. Finally, the DNA was size fractionated by electrophoresis in a 2% agarose gel and visualized by staining with ethidium bromide.
Northern blotting
Preparation of polyadenylated RNA and Northern blotting were performed as described (Burk et al., 1993) . c-myb, Pdcd4 and GAPDH mRNAs were detected with probes described previously (Burk et al., 1993; Schlichter et al., 2001a) . c-myc mRNA was detected by using a 1.2 kb EcoRI/HindIII fragment from plasmid pCDNA3wtMyc (Mink et al., 1996b) as probe. To detect bcl-2 mRNA a 2.2 kb EcoRI fragment from a chicken bcl-2 cDNA clone (pDCH-4A, Cazals-Hatem et al., 1992) was used.
Western blotting c-Myb was visualized on Western blots by using a mixture of monoclonal Myb-speci®c antibodies CB100-18 (Klempnauer et al., 1986) and 5E11 (Sleeman, 1993) . Figure 5 Expression of putative myb target genes in c-myb de®cient DT40 cells. Polyadenylated RNA isolated from wild-type (+/+), heterozygous mutant (+/7) and homozygous mutant (7/7) DT40 cells was analysed by Northern blotting using probes speci®c for bcl-2, c-myc, Pdcd4 and GAPDH
